Back to Trades
Total Value
$637.0K
Net $530.0K sold
Filing Date
Jun 18, 2026
1 transaction
Sales
$530.0K
1 transaction
Trade Summary
On Jun 18, 2026, GUGGENHIME ANDREW, PRESIDENT AND CFO, sold $637.0K of Vaxcyte, Inc. (PCVX) across 1 transaction. The filing covers Common Stock and reflects net selling of $530.0K. Reported prices ranged from $5.35 to $53.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Vaxcyte, Inc.
- Ticker Symbol
- PCVX
- CIK
- 0001649094
Insider Information
- Role
- PRESIDENT AND CFO
- Location
- SAN CARLOS, CA
Filing Details
- Filing Date
- Jun 18, 2026
- Transaction Date
- Jun 18, 2026
- Accession Number
- 0001230724-26-000010
- Form Type
- 4
- Net Trading Amount
- -$530.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Common Stock | 10,000 | $5.35 | Exercise | $53.5K |
| Jun 18, 2026 | Common Stock | 10,000 | $53.00 | Sale | $530.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | PCVX derivative | 10,000 | $5.35 | Exercise | $53.5K |
Want live alerts when GUGGENHIME ANDREW trades again?
Download Insider Trades to track PCVX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.
- (F2)Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the annuitant and the trustee.
- (F3)Option is fully vested and exercisable.